Healthquest Capital Management, L.P.
SEC-registered investment adviser.
- HQ
- TX
HealthQuest Capital Management invests in commercial stage healthcare companies that are ready to scale, using Growth Equity and Tactical Opportunities strategies. Its portfolio includes HistoSonics, Remedy Meds, Truven, and Cortex, Inc. Recent portfolio news includes a consortium of investors acquiring HistoSonics, Remedy Meds acquiring Thirty Madison, Truven acquiring Springbuk, and Boston Scientific agreeing to acquire Cortex, Inc.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Growth | Not enough dated deals | Growth, Series B |
| Sectors | Healthtech, Digital health, Medical devices | Not enough dated deals | Healthtech, Medical devices, Biotech, Digital health |
| Regions | Not stated | Not enough dated deals | CA, FL, WA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2014 | 1 | Biotech, Healthtech, Medical devices |
| 2015 | 6 | Healthtech, Medical devices, Biotech |
| 2016 | 6 | Healthtech, Medical devices, Digital health |
| 2017 | 4 | Healthtech, Medical devices, Biotech |
| 2018 | 5 | Healthtech, Biotech, Medical devices |
| 2019 | 8 | Healthtech, Medical devices, Biotech |
| 2020 | 2 | Healthtech, Medical devices, Digital health |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2015 | 0 | 0 | 0 | 1 | 3 |
| 2016 | 0 | 0 | 2 | 1 | 1 |
| 2017 | 0 | 0 | 0 | 0 | 2 |
| 2018 | 0 | 0 | 0 | 2 | 1 |
| 2019 | 0 | 0 | 0 | 1 | 6 |
| 2020 | 0 | 0 | 0 | 0 | 1 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| HealthQuest Partners IV, L.P. HealthQuest Capital invests in commercial stage healthcare companies that are ready to scale. It pursues growth equity and tactical opportunities strategies, deploying a variety of structures across services, healthcare IT, medical devices, diagnostics, and pharma services. Inferred from the firm's website | 2022 | $675M to $685.28M (Form D and SEC adviser filing) | Late investment period |
03 · People across funds
- Garheng Kong, Managing Member of the General Partner
HealthQuest Partners IV, L.P. (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.HEALTHQUESTCAPITAL.COM/
- https://www.healthquestcapital.com/contact
- https://www.healthquestcapital.com/about
- https://www.healthquestcapital.com/portfolio
- https://www.healthquestcapital.com/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026